Stocks Comparison
Concord Medical Services vs Teladoc Health: revenue, profit, margins and growth compared
Concord Medical Services brought in $65.9M of revenue in fiscal 2025, Teladoc Health $2.5B in fiscal 2025. Revenue changed by +25.2% at Concord Medical Services and -1.5% at Teladoc Health on the year before, so Concord Medical Services grew faster. Concord Medical Services kept -20.2% of its revenue as net profit, Teladoc Health -7.9%. Free cash flow was -$36.9M at Concord Medical Services and $285.5M at Teladoc Health.
Side by side, latest fiscal year
| CCM | TDOC | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $65.9M | $2.5B |
| Revenue growth | +25.2% | -1.5% |
| Net income | -$13.3M | -$200.3M |
| Net margin | -20.2% | -7.9% |
| Free cash flow | -$36.9M | $285.5M |
| Free cash flow margin | -56.1% | 11.3% |
| Earnings per share (diluted) | -$0.10 | -$1.14 |
| Cash | $42.6M | $781.1M |
| Debt | $431.3M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $15.6M | $1.1B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #351 of 646 · Health care | #97 of 646 · Health care |
Over the years
Questions about Concord Medical Services and Teladoc Health
Which is bigger by revenue, Concord Medical Services or Teladoc Health?
Teladoc Health is bigger by revenue: $2.5B in fiscal 2025, against $65.9M for Concord Medical Services in fiscal 2025.
Which keeps more of its revenue as profit, Concord Medical Services or Teladoc Health?
Concord Medical Services had a net margin of -20.2% in fiscal 2025; Teladoc Health had -7.9% in fiscal 2025.
Which grew revenue faster, Concord Medical Services or Teladoc Health?
In their latest fiscal years revenue changed by +25.2% at Concord Medical Services and -1.5% at Teladoc Health.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.